-
August 02, 2012
Bristol-Myers Squibb has suspended a mid-stage study of a hepatitis C drug obtained through its recent $2.50 billion acquisition of Inhibitex
Full story
-
July 18, 2012
Drug giant AstraZeneca has announced plans to carry out a clinical trial pitting its blood thinner Brilinta against clopidogrel in patients with peripheral artery disease (PAD).
Full story
-
February 07, 2012
In the latest episode in the long-running saga to get a new weight loss drug onto the US market, Orexigen Therapeutics has reached agreement with the FDA on the design of a cardiovascular outcomes trial required for its obesity drug Contrave
Full story
-
February 15, 2011
Merck & Co has emerged victorious in the first state court case alleging a link between jaw problems and the use of its osteoporosis drug Fosamax.
Full story
-
December 09, 2010
The Chubb Group of Insurance Companies has added three European countries to WORLDcert, its online clinical trial insurance and certificate management system.
Full story
-
August 31, 2010
Servier’s angina drug Procoralan (ivabradine) could significantly lower the risk of death and hospitalisation from chronic heart failure when added to standard CHF therapy, the results of the SHIFT trial indicate.
Full story